American Health Packaging has voluntarily recalled 1,603 cartons of Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg. The recall was initiated because the medication failed dissolution testing, meaning the drug was released faster than the required specifications. This defect was identified at the start of testing for the repackaged lot.
When a medication releases its active ingredients faster than intended, it may not provide the consistent therapeutic effect required for treatment or could potentially lead to unexpected side effects. No incidents or injuries have been reported to date in connection with this recall.
You have 2 options:
Packaged as 10-count blisters per card, 10 cards per carton; Distributed by American Health Packaging, Columbus, Ohio.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.